MDS Nordion teams with Avid Radiopharmaceuticals
Guest ContributorApril 10, 2007
MDS Nordion, Ottawa, is collaborating with Avid Radiopharmaceuticals Inc, Philadelphia PA, to conduct clinical trials for Avid's radiopharmaceuticals designed to diagnose and monitor Alzheimer's disease. MDS Nordion will radiolabel Avid compounds for use in proof-of-concept clinical trials for Avid's single proton emission computed tomography (SPECT) molecular imaging technology….
Other News
Events For Leaders in
Science, Tech, Innovation, and Policy
Discuss and learn from those in the know at our virtual and in-person events.
See Upcoming Events
You have 1 free article remaining.
Don't miss out - start your free trial today.
Start your FREE trial Already a member? Log in
By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.